Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WHY MMP licenses are treated as a NON material event

Well, those are the $64M questions. Since I'm neither, Cliff, Gloria or Carl, I can't answer the first. As for the second, all journeys begin with a first step, and you as a shareholder have the ability to try to convince those in the first question what is the correct path to take.

Share
New Message
Please login to post a reply